The Next Generation In-Vivo Discovery Platform; using technology to advance and accelerate drug development.-Larry Stevens & Abe Couse-10/10/2017 - 6:00pm

Event Information
Event Topic: 
The Next Generation In-Vivo Discovery Platform; using technology to advance and accelerate drug development.
Event Date: 
10/10/2017 - 6:00pm
Event Location: 
Wilson Sonsini Goodrich & Rosati - 650 Page Mill Road, Palo Alto
Speaker Information
Event Speaker: 
Larry Stevens & Abe Couse
Event Speaker Title: 
(LS) Vice President Technology Operations; (AC) Vice President of Marketing (Co-Presenter)
Event Speaker Company: 
Vium
Event Speaker Bio: 


Larry Stevens
Larry currently serves as Vice President of Technology Operations. He has over 20 years of experience as a development and operations executive and has led multiple product launches and product ramps in emerging and multinational companies. Prior to Vium Larry was Vice President of Operations and Embedded Systems at Robert Bosch Healthcare, where he was responsible for Global Operations, Quality / Regulatory and Hardware Development for Bosch’s medical device business unit. Prior to that, he was the Director of Operations at Think Surgical and at several additional successful companies. Larry is certified in business management, portfolio, program and project management, and holds a Bachelor of Science in Technical Management and is a US Navy veteran.


Abe Couse

Abe currently serves as Vice President of Marketing at Vium. He has over 20 years of experience in the life sciences field and has held several product management, marketing, and senior level business positions at several Bay Area life science companies including Clontech Laboratories, Becton Dickinson, Epitomics and most recently as VP of Life Science at Crown Bioscience. He has experience in launch and management of a wide range of genomic and proteomics platform technologies targeted the research and drug discovery space.

Event Details
Cost: 
$6 - Students/In-transition - Members only
$11 - Early-bird Registration - Members only
$20 - Late Registration and Non-Members
$25 - Walk-ins
Event Details: 

Vium is a Silicon Valley start-up applying hardware, and software technology aimed at improving the efficiency of drug development. The company's focus is on in vivo drug testing, a key step within the preclinical drug development pipeline where processes and methodologies have been largely unchanged for 30 years. Vium is developing a fully integrated platform including hardware, software, computer vision and data analytics backed by a cloud infrastructure. We will share the story of Vium's technology and opportunities driven by our client’s needs.

Payment Dec 12th Evening Event - $20 to TheGeneral Public

Attention B2DG members: You must login to your account first to see the members' early-bird admission rate.
If you are not a B2DG member or if you had missed the early-bird deadline, the registration fee is $20. Please follow these instructions to register.

We use PAYPAL to process your online payment. Print and bring a copy of your online receipt with you. If space permits, walk-ins are welcomed; please be prepared to pay $25 at the door (cash or check). There is no refund, exchange, or transfer. Thank you for your cooperation.
To register now, please select your meal preference from the pull-down menu below and enter the attendee's information. Then click on the "Pay Now" button to reach the PayPal payment page. Each attendee must be registered separately.
Make sure you enter the attendee's meal choice, name, and email address.


Meal Choice
Name of Attendee
Email Address